These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10637358)

  • 1. Targeting RNA with small molecules.
    Wilson WD; Li K
    Curr Med Chem; 2000 Jan; 7(1):73-98. PubMed ID: 10637358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA as a drug target: chemical, modelling, and evolutionary tools.
    Hermann T; Westhof E
    Curr Opin Biotechnol; 1998 Feb; 9(1):66-73. PubMed ID: 9503590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pneumocystis carinii group I intron ribozyme that does not require 2' OH groups on its 5' exon mimic for binding to the catalytic core.
    Testa SM; Haidaris CG; Gigliotti F; Turner DH
    Biochemistry; 1997 Dec; 36(49):15303-14. PubMed ID: 9398259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.
    Garcia-Miranda P; Becker JT; Benner BE; Blume A; Sherer NM; Butcher SE
    J Virol; 2016 Aug; 90(15):6906-6917. PubMed ID: 27194769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative ribozyme structure and function of delta agent RNA and RNA of other circular subviral RNA pathogens.
    Robertson HD; Branch AD
    Prog Clin Biol Res; 1993; 382():79-88. PubMed ID: 7684848
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators.
    Cardno TS; Shimaki Y; Sleebs BE; Lackovic K; Parisot JP; Moss RM; Crowe-McAuliffe C; Mathew SF; Edgar CD; Kleffmann T; Tate WP
    PLoS One; 2015; 10(10):e0139036. PubMed ID: 26447468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of HCV internal ribosomal entry site RNA.
    Davis DR; Seth PP
    Antivir Chem Chemother; 2011; 21(3):117-28. PubMed ID: 21233533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a selective small-molecule ligand for HIV-1 frameshift-inducing stem-loop RNA from an 11,325 member resin bound dynamic combinatorial library.
    McNaughton BR; Gareiss PC; Miller BL
    J Am Chem Soc; 2007 Sep; 129(37):11306-7. PubMed ID: 17722919
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular RNA architecture revealed by computational analysis of existing pseudoknots and ribosomal RNAs.
    Pasquali S; Gan HH; Schlick T
    Nucleic Acids Res; 2005; 33(4):1384-98. PubMed ID: 15745998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.
    Paik SY; Banerjea A; Chen CJ; Ye Z; Harmison GG; Schubert M
    Hum Gene Ther; 1997 Jun; 8(9):1115-24. PubMed ID: 9189769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA molecules with structure dependent functions are uniquely folded.
    Le SY; Zhang K; Maizel JV
    Nucleic Acids Res; 2002 Aug; 30(16):3574-82. PubMed ID: 12177299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the discovery of drug-like RNA ligands?
    Foloppe N; Matassova N; Aboul-Ela F
    Drug Discov Today; 2006 Nov; 11(21-22):1019-27. PubMed ID: 17055412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic-induced oligomerisation of group I intron RNA.
    Wank H; Schroeder R
    J Mol Biol; 1996 Apr; 258(1):53-61. PubMed ID: 8613991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of RNA-RNA duplexes with 2- or 4-thiouridines: implications for antisense design and targeting a group I intron.
    Testa SM; Disney MD; Turner DH; Kierzek R
    Biochemistry; 1999 Dec; 38(50):16655-62. PubMed ID: 10600128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on architecture of the gag-pol ribosomal frameshifting RNA in human immunodeficiency virus: a variability survey of virus genotypes.
    Qiao Q; Yan Y; Guo J; Du S; Zhang J; Jia R; Ren H; Qiao Y; Li Q
    J Biomol Struct Dyn; 2017 Jun; 35(8):1629-1653. PubMed ID: 27485859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The structure of the frameshift stimulatory signal in HIV-1 RNA: a potential target for the treatment of patients infected with HIV].
    Dulude D; Brakier-Gingras L
    Med Sci (Paris); 2006 Nov; 22(11):969-72. PubMed ID: 17101099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transcriptional Modifications Modulate rRNA Structure and Ligand Interactions.
    Jiang J; Seo H; Chow CS
    Acc Chem Res; 2016 May; 49(5):893-901. PubMed ID: 27064497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.